Page last updated: 2024-10-25

cisapride and MS (Multiple Sclerosis)

cisapride has been researched along with MS (Multiple Sclerosis) in 2 studies

Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Read, SJ1
Leggett, BA1
Pender, MP1
König, B1

Other Studies

2 other studies available for cisapride and MS (Multiple Sclerosis)

ArticleYear
Gastroparesis with multiple sclerosis.
    Lancet (London, England), 1995, Nov-04, Volume: 346, Issue:8984

    Topics: Cisapride; Female; Gastric Emptying; Gastroparesis; Humans; Middle Aged; Multiple Sclerosis; Parasym

1995
[Prokinetic drug more effective than laxatives. Despite multiple sclerosis, no enema].
    Fortschritte der Medizin, 1998, Aug-30, Volume: 116, Issue:24

    Topics: Adult; Cisapride; Constipation; Dose-Response Relationship, Drug; Drug Administration Schedule; Fema

1998